Paragon 28 

$13.1
6
+$0.01+0.08% Thursday 20:00

Statistics

Day High
13.11
Day Low
13.07
52W High
13.13
52W Low
4.65
Volume
4,215,237
Avg. Volume
2,120,667
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

13MayExpected
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.24
-0.16
-0.08
0
Expected EPS
-0.1325
Actual EPS
N/A

Financials

-21.33%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
256.18MRevenue
-54.64MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow FNA. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Paragon 28, Inc. designs, develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; and APEX 3D total ankle replacement systems; total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides bunion or hallux valgus correction systems, including nail systems phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application. Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments. The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.
Show more...
CEO
Mr. Albert DaCosta
Employees
525
Country
United States
ISIN
US69913P1057

Listings

0 Comments

Share your thoughts

FAQ

What is Paragon 28 stock price today?
The current price of FNA is $13.1 USD — it has increased by +0.08% in the past 24 hours. Watch Paragon 28 stock price performance more closely on the chart.
What is Paragon 28 stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Paragon 28 stocks are traded under the ticker FNA.
What is Paragon 28 revenue for the last year?
Paragon 28 revenue for the last year amounts to 256.18M USD.
What is Paragon 28 net income for the last year?
FNA net income for the last year is -54.64M USD.
How many employees does Paragon 28 have?
As of May 06, 2026, the company has 525 employees.
In which sector is Paragon 28 located?
Paragon 28 operates in the Health & Wellness sector.
When did Paragon 28 complete a stock split?
Paragon 28 has not had any recent stock splits.
Where is Paragon 28 headquartered?
Paragon 28 is headquartered in Englewood, United States.